METROPOLITAN LIFE INSURANCE CO/NY - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 96 filers reported holding IRADIMED CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IRADIMED CORP
ValueSharesWeighting
Q1 2024$20,455
-7.3%
4650.0%0.00%0.0%
Q4 2023$22,074
+7.0%
4650.0%0.00%0.0%
Q3 2023$20,632
-7.1%
4650.0%0.00%0.0%
Q2 2023$22,199
+21.3%
4650.0%0.00%0.0%
Q1 2023$18,298
+39.1%
4650.0%0.00%0.0%
Q4 2022$13,155
-5.9%
4650.0%0.00%0.0%
Q3 2022$13,978
-11.4%
4650.0%0.00%0.0%
Q2 2022$15,782
-24.3%
4650.0%0.00%0.0%
Q1 2022$20,851
-75.7%
465
-75.0%
0.00%0.0%
Q4 2021$85,9511,8600.00%
Other shareholders
IRADIMED CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 234,810$5,013,0005.83%
Nine Ten Capital Management LLC 277,088$5,916,0002.51%
RK Capital 211,325$4,512,0002.03%
Parkman Healthcare Partners LLC 113,855$2,431,0001.13%
Ranger Investment Management 235,312$5,024,0000.44%
CADENCE CAPITAL MANAGEMENT LLC 101,720$2,172,0000.37%
ALGERT GLOBAL LLC 30,152$644,0000.27%
Mondrian Investment Partners LTD 163,939$3,500,0000.12%
NAVELLIER & ASSOCIATES INC 20,800$444,0000.10%
GLOBEFLEX CAPITAL L P 15,510$331,0000.10%
View complete list of IRADIMED CORP shareholders